MedTrace Logo

Application of Integrated MR-PET in Patients With Gynecologic Cancers

NCT02292615 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2014-11-17

No results posted yet for this study

Summary

In this prospective cohort study, patients with newly diagnosed gynecologic cancers (including cervical, endometrial, and ovarian cancers) and patients with suspicious recurrent gynecologic cancers will be enrolled. The study period is two years and the estimated patient number is about 220. Patients will undergo image study before and after treatment. The diagnostic accuracy of MR-PET in cancer staging and the potential image biomarkers to monitor treatment response and predict treatment outcome will be investigated.

Conditions

  • MR-PET Imaging

Interventions

OTHER

Medical Imaging

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Tiffany Ting-Fang Shih, MD · Department of Medical Imaging, National Taiwan University Hospital

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2014-04-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02292615 on ClinicalTrials.gov